- Deep Dive: 3 stocks that can make you money despite a trade war or recession
- Capitol Report: SEC examination of quarterly reporting schedule focuses on balancing costs with need for disclosure
- Beware of unsolicited packages after Amazon Prime Day — they could be part of a scam
- Jeffrey Epstein’s $56 million mansion could become a real-estate nightmare
- America’s child-care crisis: ‘The entire system is experiencing pressure from every angle and something’s got to blow’
- The Moneyist: I treated my girlfriend to a vacation for paying off her car loan, but she still refuses to listen to my advice on spending money
- Outside the Box: These 16 money wasters are why so many Americans can’t save for retirement
- Deep Dive: Big banks’ earnings reports point to near-term pain and long-term opportunity
- Deep Dive: Weekend roundup: A Netflix exodus | 50th anniversary party | Can Microsoft improve from here?
- The grim reality of millennials who rely on their parents for money: ‘I pay for lunch at work, and I pay for my Netflix account’
- Led by the Chinese, foreigners are buying dramatically fewer American homes
- As the U.S. faces a massive heat wave, don’t make these 3 mistakes when you turn on your air conditioning
- Read this before using FaceApp — you give up more personal data than you realize on this Russian-made app
- Extreme heat kills more than 600 Americans a year — here are the best ways to stay cool
- On the 50th anniversary of the Moon landing, thank NASA for memory foam, pet odor filters — and GPS on your iPhone
- Netflix CEO Reed Hastings may have missed the real reason why U.S. subscriber numbers plunged
- Market Snapshot: Stock-market futures rise even as Fed clarifies dovish comments made by Williams
- Need to Know: Expect a ‘10% correction in the next three months’, warns Morgan Stanley’s chief investment officer
- Bond Report: Treasury yields hold ground as Fed remains in focus
- ‘Welcome home, Ilhan!’ chant rings out as Rep. Omar gets hero’s welcome in Minnesota
Most Popular Stocks - AMEX/NASDAQ/NYSE
Interested in a stock? Thinking of buying or selling?
Market Snapshot
- After-Hours Report: Weekly Wrap
- After-Hours Report: CRWD +10%, SKX +9%, CHWY +4%, COF +3.4%, MSFT +1% on earnings/guidance
- After-Hours Report: EBAY +5%, LLNW -19%, NFLX -11% on earnings/guidance
- After-Hours Report: CSX -5%, SGEN +8%, CTAS +6% on earnings/guidance
- After-Hours Report: JBHT +6.5% on earnings/guidance
1. Enter company stock symbol in the Stock Ticker Search bar (Example: AAPL)
2. Read what people are saying about the stock and communicate your own views. TickerData
compiles data across Twitter, Facebook and other social media sites to bring you the latest information.
Sign up for your FREE account today and get access to additional stock information!
Stocks Up on Unusual Volume
Stocks Down on Unusual Volume
Upgrades and Downgrades
- EHTH: First Analysis Sec starts at Outperform
- MYL: Wolfe Research starts at Outperform
- BHC: Wolfe Research starts at Outperform
- TEVA: Wolfe Research starts at Peer Perform
- V: Barclays reits Overweight
- MA: Barclays reits Overweight
- CRWD: Barclays reits Overweight
- ANCUF: BMO Capital Markets cuts to Market Perform
- ISRG: Canaccord Genuity reits Buy
- MSFT: Canaccord Genuity reits Buy
- SAP: Deutsche Bank cuts to Hold
- ATHM: The Benchmark Company cuts to Hold
- ASOMF: Barclays cuts to Equal Weight
- MSFT: Oppenheimer reits Outperform
- INDB: Compass Point ups to Buy
- DOW: Cowen starts at Market Perform
- VFC: Pivotal Research Group reits Hold
- DECK: Pivotal Research Group reits Hold
- CRWD: Needham reits Buy
- DHR: Needham reits Buy
IPO News
- US IPO Weekly Recap: Medallia tops a 9-IPO week with a 76% first day return
- Cannabis SPAC Silver Spike Acquisition Corp files for a $250 million IPO
- US IPO Week Ahead: The IPO marathon continues in a 7-deal week featuring health-tech
- Radio network provider Ondas Holdings sets terms for $47 million IPO
- Intercorp Financial prices US IPO at $46, within the range
- Afya prices IPO at $19, above the range
- Medallia prices IPO at $21, above the range
- Mexican E&P Vista Oil & Gas sets terms for $95 million US IPO
- Kansas bank CrossFirst Bankshares files for a $100 million IPO
- iHeartMedia completes Nasdaq direct listing
- Cancer biotech Genmab prices US IPO at $17.75
- Liver disease biotech Mirum Pharmaceuticals prices IPO at $15 midpoint
- Phreesia prices upsized IPO at $18, above the range
- AssetMark Financial prices IPO at $22, above the range
- Fintech SPAC Thunder Bridge Acquisition II files for a $300 million IPO
- Consumer-focused SPAC Conyers Park II Acquisition Corp prices $400 million IPO at $10
- Oaktree Capital's SPAC Oaktree Acquisition Corp prices $175 million IPO at $10
- Fulcrum Therapeutics prices IPO at $16, the low end of the range
- Money moves: Personal lender Oportun Financial files for a $50 million IPO
- DouYu International prices IPO at $11.50, the low end of the range